These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 31938423

  • 1. miR-27a protects against acute lung injury in LPS-treated mice by inhibiting NF-κB-mediated inflammatory response.
    Li W, Qiu X, Liu J, Han Y, Wei D, Ji G, Jiang H.
    Int J Clin Exp Pathol; 2018; 11(6):2980-2989. PubMed ID: 31938423
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M, Liu B, He H, Gu Z, Liu Y, Su Y, Zhu D, Cang J, Luo Z.
    Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel alleviated liver injury of septic mice by alleviating inflammatory response via microRNA-27a/TAB3/NF-κB signaling pathway.
    Yang Q, Zhang D, Li Y, Li Y, Li Y.
    Biomed Pharmacother; 2018 Jan; 97():1424-1433. PubMed ID: 29156532
    [Abstract] [Full Text] [Related]

  • 4. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
    Huang Y, Huang L, Zhu G, Pei Z, Zhang W.
    J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
    Fu L, Zhu P, Qi S, Li C, Zhao K.
    Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of miR-let-7e attenuates LPS-induced acute lung injury in mice via inhibiting pulmonary inflammation by targeting SCOS1/NF-κB pathway.
    Li W, Zhang W, Liu J, Han Y, Jiang H, Ji G, Liu W.
    Biosci Rep; 2021 Jan 29; 41(1):. PubMed ID: 33392621
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway.
    Wang T, Jiang L, Wei X, Dong Z, Liu B, Zhao J, Wang L, Xie P, Wang Y, Zhou S.
    Cell Cycle; 2019 Aug 29; 18(16):1893-1907. PubMed ID: 31208297
    [Abstract] [Full Text] [Related]

  • 8. Suppressed nuclear factor-kappa B alleviates lipopolysaccharide-induced acute lung injury through downregulation of CXCR4 mediated by microRNA-194.
    Chen R, Xie F, Zhao J, Yue B.
    Respir Res; 2020 Jun 10; 21(1):144. PubMed ID: 32522221
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MicroRNA-27a alleviates IL-1β-induced inflammatory response and articular cartilage degradation via TLR4/NF-κB signaling pathway in articular chondrocytes.
    Qiu WJ, Xu MZ, Zhu XD, Ji YH.
    Int Immunopharmacol; 2019 Nov 10; 76():105839. PubMed ID: 31520995
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of miR-145-5p alleviated LPS-induced acute lung injury.
    Yu YL, Yu G, Ding ZY, Li SJ, Fang QZ.
    J Biol Regul Homeost Agents; 2019 Nov 10; 33(4):1063-1072. PubMed ID: 31353880
    [Abstract] [Full Text] [Related]

  • 16. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X, Sun CY, Zhang YB, Guo HZ, Feng XX, Peng SZ, Yuan J, Zheng RB, Chen WP, Su ZR, Huang XD.
    J Ethnopharmacol; 2016 Jun 20; 186():91-102. PubMed ID: 27036629
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
    Jiang Q, Yi M, Guo Q, Wang C, Wang H, Meng S, Liu C, Fu Y, Ji H, Chen T.
    Int Immunopharmacol; 2015 Dec 20; 29(2):370-376. PubMed ID: 26507165
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3.
    Li P, Yao Y, Ma Y, Chen Y.
    Int Immunopharmacol; 2019 Oct 20; 75():105794. PubMed ID: 31398659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.